MILBY RANDY
SEC insider (Form 3/4/5 filer). CIK 0001360968. CEO at Tharimmune, Inc. (THAR). 5 reported Form 4/5 transactions since Sep 2024; latest on Jan 13, 2025. Located in BRIDGEWATER, NJ.
Companies MILBY RANDY has filed insider reports for
- Tharimmune, Inc. (THAR): Director, Officer, CEO
MILBY RANDY
CIK: 0001360968
Transaction Breakdown
Open Market Buys (P)4 (80.0%)
High conviction signal
Open Market Sales (S)0 (0.0%)
Position reduction
Option Exercises (M)0 (0.0%)
Derivative conversions
Awards (A)1 (20.0%)
Compensation grants
Other (G, F, J, C, D, …)0 (0.0%)
Gifts, tax withholding, conversions, dispositions to the issuer and other codes
Companies & Roles (1)
THAR
Tharimmune, Inc.
DirectorOfficer
Discretionary Trading P&L
Holdings
Transaction History (5 total)
- Jan 13, 2025THAR
Tharimmune, Inc.
AwardDirectOptions (right to buy)
81K shares- - Dec 19, 2024THAR
Tharimmune, Inc.
PurchaseDirect4.6K shares at avg. $2.12$10K - Oct 8, 2024THAR
Tharimmune, Inc.
PurchaseDirect1.5K shares at avg. $2.08$3K - Oct 8, 2024THAR
Tharimmune, Inc.
PurchaseDirect646 shares at avg. $2.09$1K - Oct 8, 2024THAR
Tharimmune, Inc.
PurchaseDirect354 shares at avg. $2.10$743.4
| Type | Shares | Price | Ownership | |||
|---|---|---|---|---|---|---|
| Jan 13, 2025 | THAR Tharimmune, Inc. | Award Options (right to buy) | 80,958 | - | - | Direct |
| Dec 19, 2024 | THAR Tharimmune, Inc. | Purchase | 4,600 | $2.12 | $9,752 | Direct |
| Oct 8, 2024 | THAR Tharimmune, Inc. | Purchase | 1,500 | $2.08 | $3,128 | Direct |
| Oct 8, 2024 | THAR Tharimmune, Inc. | Purchase | 646 | $2.09 | $1,350 | Direct |
| Oct 8, 2024 | THAR Tharimmune, Inc. | Purchase | 354 | $2.10 | $743 | Direct |
1-5 of 5 transactions